newsfilter
← Latest News
GlobeNewswire·

miRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

BOULDER, Colo., Feb. 06, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted...